ESMO open
Corrigendum to "Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028": [ESMO Open 10 (2025) 104295].
M Donia, H Jespersen, M Jalving, R Lee, H Eriksson, C Hoeller, M Hernberg, I Gavrilova, L Kandolf, G Liszkay, H Helgadottir, A Zhukavets, D Pjanova, I Marquez-Rodas, B Neyns
Published: 202610.1016/j.esmoop.2025.105492
No abstract available for this study.